5 Unusual Movers in the S&P 500
In the S&P 500, some stocks had significant moves this past week, and some were on exponential volume spikes as well.
All Work
Chris Lange
Why Oppenheimer Sees Netflix Going to the Moon
Oppenheimer reiterated an Outperform rating on Netflix shares and increased its price target to to the higher end of the spectrum among analysts.
Why Analyst Expects Bad BlackBerry Earnings Fallout
Credit Suisse opines on where BlackBerry stands to go from here in its most recent report, including its ability to ramp up software and operate more competitively.
Why the Office Depot Merger Approval Still Has Many Hurdles
The office products space has been an industry in consolidation, and now we are closer to the three major players completing their consolidation into one.
Healthways Trips Over Revised Guidance
Healthways announced that it will revise its guidance for 2015 due to lower than expected revenue from a single health plan contract and slower than expected business development for a couple projects.
Smith & Wesson Stumbles Over Guidance
Smith & Wesson reported better-than-expected fiscal fourth-quarter financial results Thursday after the markets closed.
Why Credit Suisse Prefers T-Mobile and AT&T
Credit Suisse hosted its second annual 1-1 Telecom Services Conference with the chief financial officers of AT&T, Verizon Communications and T-Mobile.
Why It Matters That GM Is Now Investment Grade At Fitch
courtesy of General MotorsGeneral Motors Company (NYSE: GM) is making waves in the market Thursday because it is back to investment grade. Fitch was behind the upgrade, and it was based on GM’s improving…
What to Expect From CarMax Earnings
CarMax is scheduled to report its fiscal first-quarter financial results Friday before the U.S. markets open.
Key Analyst Sees Solid Upside in Eli Lilly
Eli Lilly has made a big splash in the market over the past year. A key analyst sees this trend continuing despite some potential near-term headwinds.
Why a Key Analyst Sees Increased iPhone Growth, as iPad Fades
Apple is continuing to improve its products and the outlook is incredibly positive. Merrill Lynch predicts that this trend will continue for the iPhone.
Kroger Keeps Same-Store Sales Streak Alive
Kroger reported disappointing fiscal first-quarter earnings Thursday before the markets opened.
Analysts Stand by Oracle After Disappointing Earnings
Oracle was maintained as Outperform at Credit Suisse, as Hold at Jefferies and at Buy at Merrill Lynch.
How Macro Headwinds Are Holding Back Oracle
Wikimedia CommonsOracle Corp. (NYSE: ORCL) reported its fiscal fourth-quarter financial results Wednesday after the markets closed as $0.78 in earnings per share (EPS) on $10.7 billion in revenue compared to Thomson Reuters consensus estimates…
How Tesla Aims to Lower Its Massive Battery Costs
According to the outlook of a key market guru, Tesla is paving an environmentally friendly way to the future that investors might not want to pass up.
What to Expect From Kroger Earnings
Kroger is scheduled to report its fiscal first-quarter earnings Thursday before the U.S. markets open.
How Rite Aid Could Handily Beat Earnings Expectations
Rite Aid is scheduled to report its fiscal first-quarter financial results before the markets open Thursday morning.
Key Management Reshuffle Inside Microsoft
Microsoft is looking to shake things up. The company plans to shift some of its senior leaders around in an effort to address evolving trends within its space.
What Allergan Is Looking to Add With Kythera
Allergan and Kythera Biopharmaceuticals announced that they have entered into a definitive agreement in which the former will acquire he latter in a cash and equity transaction valued at roughly $2.1 billion.
How Synergy Is Bringing the Ultimate Relief to Shareholders
If a drug is approved or passes a clinical trial, there can be a huge upside for the stock, like what Synergy Pharmaceuticals experienced Wednesday.